CMS Reveals Limited Digital Health Policies in Final Medicare Rule


In a move that has drawn considerable attention just days before the 2024 presidential election, the Centers for Medicare & Medicaid Services (CMS) has released the final calendar year 2025 physician fee schedule (PFS) rule. This rule, which impacts digital therapeutics, telehealth, rural health clinics, and opioid treatment programs, underscores CMS’s limited authority in shaping digital health payment policies.
Digital Health Policies
CMS has finalized several digital health policies, as initially proposed in July’s draft rule. However, the offerings remain modest. New codes have been introduced for digital therapeutics, particularly aimed at mental healthcare. These changes mainly involve redefining existing codes to distinguish them from remote therapeutic monitoring codes. CMS’s authority in this area is limited, prompting a call for congressional action to create a new benefit category for digital therapeutics.
Telehealth Policies
With the expiration of Medicare telehealth flexibilities looming at the end of 2024, CMS has highlighted the necessity for Congress to extend key telehealth waivers. These waivers have significantly expanded telehealth services since 2020. Permanent coverage for audio-only visits and direct supervision via telehealth has been confirmed, yet geographical and origin site restrictions continue to pose challenges. For further details, you can refer to the original article.
Rural Health Clinics and Federally Qualified Health Centers
CMS has been striving to achieve payment parity for telehealth services compared to in-person services in rural health clinics and federally qualified health centers. While a special payment rate is applied for telehealth, CMS has opted to retain its current payment methodology for now, though reforms may be considered in the future.
Opioid Treatment Programs
The rule acknowledges the importance of telehealth in opioid treatment programs, especially for older Medicare beneficiaries who rely heavily on audio-only services. CMS will allow telehealth usage for periodic assessments, marking a step forward in addressing opioid use disorder through digital means.
For a comprehensive understanding of the finalized rule and its implications, visit the CMS Federal Register.

Conclusion


While CMS has made some progress, the agency emphasizes the need for congressional action to broaden and secure these developments. The future of digital health policies remains uncertain, with much depending on legislative support.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Is Florida’s Booming Real Estate Market Becoming Unaffordable?

Florida is facing a real estate crisis marked by skyrocketing insurance premiums, stringent FEMA rules, and a surge in hedge fund property acquisitions.

By |November 14, 2024|Categories: Article, Finance/Economy, Real Estate|Tags: , |0 Comments

Revolutionizing Cancer Therapy: The Promise of Patient-Derived Organoids

Patient-derived organoids offer an unprecedented opportunity to replicate the complex structure and genetic makeup of cancers, providing a more accurate model for clinical drug screening and pharmacognostic assessment.

The AI Revolution in Dermatology: A Systematic Review

In a groundbreaking study published in Nature, researchers have delved into the burgeoning field of artificial intelligence (AI) in dermatology, specifically examining its role in diagnosing skin cancer. The study, titled "A Systematic Review and Meta-Analysis of Artificial Intelligence Versus Clinicians for Skin Cancer Diagnosis," offers a comprehensive look at how AI stacks up against human clinicians in this critical area of healthcare.

By |November 14, 2024|Categories: AI in Healthcare, Article, Dermatology|Tags: , |0 Comments

The Fast Lane to Fully Autonomous Vehicles: Industry Innovations and Future Prospects

The automotive world is abuzz with announcements from major players like Tesla, Rimac, Renault, and Nissan, each unveiling plans to introduce autonomous vehicles in the near future. Tesla's much-anticipated "CyberCab" is set for an October 2024 debut, while Rimac and Renault are gearing up for releases in 2026.

Futureproofing for Insurers: The Role of AI and Hyper-Personalization

In a rapidly evolving industry, insurance companies are turning to artificial intelligence (AI) and hyper-personalization to stay ahead of the curve.

Revolutionizing Healthcare: The Power and Potential of AI

AI technology offers a multitude of benefits, from enhancing patient outcomes to reducing healthcare costs and improving population health. Its application ranges from preventive screenings to complex diagnostic procedures, marking a new era in medical care.

By |November 13, 2024|Categories: Article, Artificial Intelligence, Healthcare|Tags: , |0 Comments